J&J Switches Benacort Hayfever Spray From Rx To GSL Status In The UK
Executive Summary
J&J switches its Benacort hayfever nasal spray from prescription-only to general sales list status in the UK, making it the third mass market steriod-based spray available outside pharmacy.
You may also be interested in...
Sanofi Switch Gives UK Hay Fever Sufferers Additional Mass Market Option
Sanofi has switched its Allevia hay fever tablets (fexofenadine hydrochloride) in the UK, from prescription-only to general sales list status.
J&J Leverages Power Of Digital Personalization With Nicorette UK Extension
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.
Balancing Beauty Lineup With International And Regional Brands Factors In J&J Consumer Growth
While J&J benefits from “underlying strength” of its large skin care brands, it targets “regular additions of local, smaller brands,’ says global consumer business head Thibaut Mongon. Portfolio balance of international and localized brands helps it weather economic uncertainty during the COVID-19 pandemic.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: